Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study

被引：0
|
作者：
Yuanle Deng
Han Hu
Rong Jia
Wei Dai
Dengfeng Wang
Purong Zhang
Peng Zhang
Kai Cheng
Jianning Tang
Yan Wen
Xiang Zhou
Qiuling Shi
Zhujuan Xiong
Jin Zhou
机构：
[1] Sichuan Cancer Hospital & Institute,Department of Clinical Nutrition, Sichuan Clinical Research Center for Cancer
[2] Sichuan Cancer Center,Department of Medical Oncology, Sichuan Clinical Research Center for Cancer
[3] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer
[4] Sichuan Cancer Hospital & Institute,Gynecologic Oncology Center, Sichuan Clinical Research Center for Cancer
[5] Sichuan Cancer Center,Department of Breast Surgery, Sichuan Clinical Research Center for Cancer
[6] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer
[7] Sichuan Cancer Hospital & Institute,Department of Pharmacy, Sichuan Clinical Research Center for Cancer
[8] Sichuan Cancer Center,Department of Gastrointestinal Surgery, Sichuan Clinical Research Center for Cancer
[9] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,School of Public Health
[10] Sichuan Cancer Hospital & Institute,undefined
[11] Sichuan Cancer Center,undefined
[12] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined
[13] Sichuan Cancer Hospital & Institute,undefined
[14] Sichuan Cancer Center,undefined
[15] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined
[16] Sichuan Cancer Hospital & Institute,undefined
[17] Sichuan Cancer Center,undefined
[18] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined
[19] Sichuan Cancer Hospital & Institute,undefined
[20] Sichuan Cancer Center,undefined
[21] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined
[22] Sichuan Cancer Hospital & Institute,undefined
[23] Sichuan Cancer Center,undefined
[24] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined
[25] Chongqing Medical University,undefined
来源：
BMC Pulmonary Medicine | / 23卷
关键词：
Patient-reported outcome; Lung cancer; Immunotherapy; Immune-related adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study
    Deng, Yuanle
    Hu, Han
    Jia, Rong
    Dai, Wei
    Wang, Dengfeng
    Zhang, Purong
    Zhang, Peng
    Cheng, Kai
    Tang, Jianning
    Wen, Yan
    Zhou, Xiang
    Shi, Qiuling
    Xiong, Zhujuan
    Zhou, Jin
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [2] Electronic patient-reported outcome measured in patients with pancreatic cancer receiving second-line chemotherapy: A multicenter prospective observational study.
    Ohba, Akihiro
    Takumoto, Yuki
    Terashima, Takeshi
    Ueno, Makoto
    Kobayashi, Satoshi
    Ikezawa, Kenji
    Okano, Naohiro
    Fujimori, Nao
    Tsumura, Hidetaka
    Murohisa, Go
    Ohya, Ayano
    Yamashita, Tatsuya
    Ozaka, Masato
    Ikeda, Masafumi
    Okusaka, Takuji
    Morizane, Chigusa
    Narimatsu, Hiroto
    Akazawa, Manabu
    Shiroiwa, Takeru
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 682 - 682
  • [3] Patient reported toxicities: Development and validation of patient-reported symptom measure for lung cancer patients receiving immunotherapy.
    Shaw, Sandra S.
    Jim, Heather S. L.
    Eisel, Sarah
    Hoogland, Aasha
    Leduc, David
    Dicker, Adam P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [4] Developing and validating utility parameters to establish patient-reported outcome-based perioperative symptom management in patients with lung cancer: a multicentre, prospective, observational cohort study protocol
    Dai, Wei
    Xie, Shaohua
    Zhang, Rui
    Wei, Xing
    Wu, Chuanmei
    Zhang, Yuanqiang
    Feng, Wenhong
    Liao, Xiaoqing
    Mu, Yunfei
    Zhou, Heling
    Cheng, Xuemei
    Jiang, Yanhua
    He, Jintao
    Li, Qiang
    Yang, Xiaojun
    Shi, Qiuling
    BMJ OPEN, 2019, 9 (10):
  • [5] Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
    Li, Hongxin
    Zhao, Wen
    Chang, Caiyun
    Xuan, Tiantian
    Wang, Chengjun
    Zhang, Rongyu
    Yang, Chuang
    Wang, Jian
    Yi, Cuihua
    Wang, Xiuwen
    Yu, Shuwen
    Li, Jisheng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [6] Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol
    Liang, Ying
    Jing, Pengyu
    Gu, Zhongping
    Shang, Lei
    Ge, Peng
    Zhang, Yong
    Wang, Lv
    Qiu, Chun
    Zhu, Ximing
    Tan, Zhijun
    TRIALS, 2024, 25 (01)
  • [7] Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol
    Ying Liang
    Pengyu Jing
    Zhongping Gu
    Lei Shang
    Peng Ge
    Yong Zhang
    Lv Wang
    Chun Qiu
    Ximing Zhu
    Zhijun Tan
    Trials, 25
  • [8] Development of a hospital-based patient-reported outcome framework for lung cancer patients: a study protocol
    Natasha Moloczij
    Karla Gough
    Benjamin Solomon
    David Ball
    Linda Mileshkin
    Mary Duffy
    Mei Krishnasamy
    Health and Quality of Life Outcomes, 16
  • [9] Development of a hospital-based patient-reported outcome framework for lung cancer patients: a study protocol
    Moloczij, Natasha
    Gough, Karla
    Solomon, Benjamin
    Ball, David
    Mileshkin, Linda
    Duffy, Mary
    Krishnasamy, Mei
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2018, 16
  • [10] PATIENT-REPORTED OUTCOMES (PRO) IN A FIRST-LINE STUDY (20060314) OF PANITUMUMAB plus FOLFIRI IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)
    Karthaus, M.
    Resch, G.
    Mineur, L.
    Hofheinz, R.
    Greil, R.
    Letocha, H.
    Fernebro, E.
    Gamelin, E.
    DeCosta, L.
    Koehne, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 75 - 75
12345